Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Benethera (shaoxing) Biotechnology Co., Ltd.

Clinical trials sponsored by Benethera (shaoxing) Biotechnology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New oral drug for inflammatory bowel disease enters first human tests Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New oral drug for inflammatory bowel disease enters first human tests

Disease control Recruiting now

This early-stage trial tests BDHK-2009, an experimental tablet for inflammatory bowel diseases like ulcerative colitis and Crohn's disease. The study involves 68 healthy adults aged 18 to 55 to see if the drug is safe and how the body handles it. Participants receive either a sin…

Phase 1 • Sponsor: Benethera (Shaoxing) Biotechnology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC